Expanding Rental Laboratory and Office Business in U.S. Mitsui Fudosan to Participate in Innovation Square Phase III Project in Boston May 23, 2024 Mitsui Fudosan.
Gene-editing technique, CRISPR, has made a remarkable leap from laboratory research to practical medicine by offering a groundbreaking treatment for sickle-cell disease.
As more than 8,000 biotech executives, investors and analysts converge this week for the 42nd Annual J.P. Morgan Healthcare Conference the largest biotech business meeting of the year industry leaders see reasons to be optimistic.